Cargando…

Does incorporation of aids/devices and help, make a difference in the childhood health assessment questionnaire disability index? Analysis from the printo juvenile idiopathic arthritis database

Detalles Bibliográficos
Autores principales:	Saad-Magalhães, C, Pistorio, A, Ravelli, A, Brik, R, Mihaylova, D, Ten Cate, R, Andersson-Gare, B, Ferriani, V, Minden, K, Hashkes, P, Rygge, M, Sauvain, MJ, Venning, H, Martini, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333903/ http://dx.doi.org/10.1186/1546-0096-6-S1-P108

Ejemplares similares

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
por: Filocamo, G, et al.
Publicado: (2008)

The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients
por: Giancane, Gabriella, et al.
Publicado: (2019)

Therapeutic approaches for the treatment of new onset and flared juvenile systemic lupus erythematosus with active renal disease: an international multicenter PRINTO study
por: Miettunen, P, et al.
Publicado: (2011)

PRINTO scholarships: the Italian experience
por: Munitis, Pablo Garcia
Publicado: (2007)

Clinically inactive disease in juvenile dermatomyositis – a proposed revision to the printo criteria
por: Almeida, Beverley, et al.
Publicado: (2014)

Nearly 20% of children are not correctly classified according to current ilar classification in a PRINTO dataset of more than 12,000 juvenile idiopathic arthritis patients
por: Consolaro, Alessandro, et al.
Publicado: (2014)

A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials
por: Demirkaya, E, et al.
Publicado: (2011)

Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey
por: Gattorno, M, et al.
Publicado: (2008)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
por: Verazza, S, et al.
Publicado: (2008)

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
por: Consolaro, A, et al.
Publicado: (2008)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
por: Filocamo, G, et al.
Publicado: (2008)

IgA vasculitis in adults: the performance of the EULAR/PRINTO/PRES classification criteria in adults
por: Hočevar, Alojzija, et al.
Publicado: (2016)

Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis
por: Meiorin, S, et al.
Publicado: (2008)

Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA)
por: Magnani, A, et al.
Publicado: (2008)

Musculoskeletal ultrasound versus magnetic resonance in supporting clinical management of juvenile idiopathic arthritis
por: Lanni, Stefano, et al.
Publicado: (2014)

PReS-FINAL-2164: Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis
por: Pignataro, R, et al.
Publicado: (2013)

2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis
por: Malattia, C, et al.
Publicado: (2008)

Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
por: Palmisani, Elena, et al.
Publicado: (2007)

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
por: Ferrari, C, et al.
Publicado: (2008)

Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology
por: Bovis, Francesca, et al.
Publicado: (2018)

Predictive Value of Magnetic Resonance Imaging in Patients With Juvenile Idiopathic Arthritis in Clinical Remission
por: Mazzoni, Marta, et al.
Publicado: (2022)

Evaluation of macrophage activation syndrome in hospitalised patients with Kikuchi-Fujimoto disease based on the 2016 EULAR/ACR/PRINTO classification criteria
por: Ahn, Sung Soo, et al.
Publicado: (2019)

Differentiating children with familial Mediterranean fever from other recurrent fever syndromes: The utility of new Eurofever/PRINTO classification criteria
por: Kışla Ekinci, Rabia Miray, et al.
Publicado: (2021)

Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients
por: Solari, N, et al.
Publicado: (2008)

Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America
por: Trail, L, et al.
Publicado: (2008)

Macrophage activation syndrome (MAS) in juvenile systemic lupus erythematosus (JSLE): an underrecognized complication?
por: Parodi, A, et al.
Publicado: (2008)

Development and initial validation of a new short and simple Health-Related Quality Of Life (HRQL) Questionnaire for Pediatric Rheumatic Diseases (PRD)
por: Palmisani, E, et al.
Publicado: (2008)

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs
por: Consolaro, A, et al.
Publicado: (2013)

PReS-FINAL-2010: Predictive value of whole-body MRI in juvenile dermatomyositis
por: Malattia, C, et al.
Publicado: (2013)

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
por: Varnier, GC, et al.
Publicado: (2013)

PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
por: Malattia, C, et al.
Publicado: (2013)

HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis
por: Berntson, L, et al.
Publicado: (2008)

PReS13-SPK-1332: Assessment of disease activity and damage in juvenile idiopathic arthritis
por: Ravelli, A
Publicado: (2013)

Development and initial validation of a new functional ability tool for juvenile dermatomyositis
por: Varnier, GC, et al.
Publicado: (2011)

PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
por: Negro, G, et al.
Publicado: (2013)

Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction
por: Nagler, Michael, et al.
Publicado: (2018)

Sleep disorders in patients with juvenile idiopathic arthritis as assessed by the sleep disturbance scale for children
por: Khubchandani, RP, et al.
Publicado: (2011)

A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis
por: Bracciolini, GP, et al.
Publicado: (2014)

Comics as an educational tool for children with juvenile idiopathic arthritis
por: Mendelson, Amir, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n946o66t1qvve93iadb2uivotr